Publicacións (240) Publicacións nas que participase algún/ha investigador/a

2024

  1. Are New Ultra-Rapid-Acting Insulins Associated with Improved Glycemic Control and Reduced Hypoglycemia in Comparison to Conventional Rapid-Acting Insulins for Individuals with Type 1 and Type 2 Diabetes? A Systematic Review and Meta-Analysis

    Diabetes Technology and Therapeutics

  2. Improved guidance is needed to optimise diagnostics and treatment of patients with thyroid cancer in Europe

    Endocrine, Vol. 83, Núm. 3, pp. 585-593

  3. Semaglutide modulates prothrombotic and atherosclerotic mechanisms, associated with epicardial fat, neutrophils and endothelial cells network

    Cardiovascular Diabetology, Vol. 23, Núm. 1

  4. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Correction: RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas (Oncogene, (2021), 40, 45, (6354-6368), 10.1038/s41388-021-02009-8)

    Oncogene

  2. Diagnosis and Management of Malnutrition in Patients with Heart Failure

    Journal of Clinical Medicine, Vol. 12, Núm. 9

  3. Executive summary of the expert consensus document from the Spanish Society of Neurosurgery and the Spanish Society of Endocrinology and Nutrition: Clinical recommendations on the perioperative management of pituitary tumors

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 9, pp. 592-608

  4. Executive summary of the expert consensus document from the Spanish Society of Neurosurgery and the Spanish Society of Endocrinology and Nutrition: Clinical recommendations on the perioperative management of pituitary tumors

    Neurocirugia, Vol. 34, Núm. 6, pp. 292-307

  5. GALIPDIA study: Reaching lipid targets in a population with type 2 diabetes (T2DM) from the Northwest of Spain

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 1, pp. 29-38

  6. Hypopituitarism after traumatic brain injury in adults: Clinical guidelines of the neuroendocrinology area of the Spanish Society of Endocrinology and Nutrition (SEEN)

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 9, pp. 584-591

  7. Magnetic resonance imaging as a predictor of therapeutic response to pasireotide in acromegaly

    Clinical Endocrinology, Vol. 99, Núm. 4, pp. 378-385

  8. Mortality in Acromegaly Diagnosed in Older Individuals in Spain Is Higher in Women Compared to the General Spanish Population

    The Journal of clinical endocrinology and metabolism, Vol. 108, Núm. 9, pp. 2193-2202

  9. Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly

    Frontiers in Endocrinology, Vol. 14

  10. Should we suspect primary aldosteronism in patients with hypokalaemic rhabdomyolysis? A systematic review

    Frontiers in Endocrinology, Vol. 14

2022

  1. A practical approach to semaglutide use in patients with type-2 diabetes

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SD, pp. 1-9

  2. Acromegaly disease activity according to ACRODAT®, a cross-sectional study in Spain: ACROVAL study

    Endocrine, Vol. 75, Núm. 2, pp. 525-536

  3. Data mining analyses for precision medicine in acromegaly: a proof of concept

    Scientific Reports, Vol. 12, Núm. 1

  4. Factors associated with therapeutic response in acromegaly diagnosed in the elderly in Spain

    Frontiers in Endocrinology, Vol. 13

  5. Gestational weight gain influences neonatal outcomes in women with obesity and gestational diabetes

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 10, pp. 852-858

  6. Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response

    Biomedicines, Vol. 10, Núm. 2